Comprehensive Review on Nanostructured Lipid Carriers

Nanostructured lipid carriers (NLCs) represent a novel nanoparticulate drug delivery system composed of solid lipids, liquid lipids, emulsifying agents, and an aqueous phase. In recent years, NLCs have garnered considerable scientific and clinical interest due to their superior drug delivery capabilities, offering notable advantages over conventional dosage forms. Nanostructured lipid carriers (NLCs) are second generation lipid-based nanocarriers formulated using biocompatible solid lipids, liquid lipids, surfactants, and co-surfactants. These systems are capable of encapsulating a wide range of pharmacological agents, offering controlled drug release, improved drug stability and scalability for industrial production without the requirement for organic solvents. This article provides a comprehensive overview of nanostructured lipid carriers (NLCs), focusing on their structural composition, preparation techniques, characterization methods, and the advantages they offer over first-generation lipid-based nanoparticles.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-20
DOI
https://doi.org/10.5281/zenodo.15474136
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive Review on Nanostructured Lipid Carriers

Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
article

Comprehensive Review on Nanostructured Lipid Carriers

article en

Abstract

Nanostructured lipid carriers (NLCs) represent a novel nanoparticulate drug delivery system composed of solid lipids, liquid lipids, emulsifying agents, and an aqueous phase. In recent years, NLCs have garnered considerable scientific and clinical interest due to their superior drug delivery capabilities, offering notable advantages over conventional dosage forms. Nanostructured lipid carriers (NLCs) are second generation lipid-based nanocarriers formulated using biocompatible solid lipids, liquid lipids, surfactants, and co-surfactants. These systems are capable of encapsulating a wide range of pharmacological agents, offering controlled drug release, improved drug stability and scalability for industrial production without the requirement for organic solvents. This article provides a comprehensive overview of nanostructured lipid carriers (NLCs), focusing on their structural composition, preparation techniques, characterization methods, and the advantages they offer over first-generation lipid-based nanoparticles.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 64%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comprehensive Review on Nanostructured Lipid Carriers · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS